Functional Tumor Profiling / EVA-PCD
Ex vivo testing of living tumor samples to measure programmed cell death and guide drug selection.
Functional Tumor Profiling
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Functional Tumor Profiling Means in Everyday Medical Language
Functional Tumor Profiling, often called EVA-PCD, is a laboratory test that examines living tumor cells taken from a patient’s biopsy or surgery. These tumor cells are kept alive outside the body in a controlled lab setting. Doctors expose the cells to different chemotherapy or targeted drugs to see which ones cause the tumor cells to undergo programmed cell death—a natural process where damaged or unwanted cells die. This helps identify which treatments might be most effective for that patient’s specific tumor.
Why Functional Tumor Profiling Can Matter in Cancer Care
Tumors can respond differently to treatments, so this test aims to personalize therapy by finding drugs more likely to kill the patient’s cancer cells. Unlike standard treatment decisions based mainly on tumor type or genetic markers, EVA-PCD looks directly at how the patient’s tumor cells react to drugs. This can sometimes help guide treatment choices, especially when standard options have been exhausted or when doctors want additional information about drug effectiveness.
What Patients Might See or Hear About Functional Tumor Profiling
Patients may encounter the term EVA-PCD or Functional Tumor Profiling in medical reports, treatment plans, or discussions with their care team. The test might also appear under related names like EVA-PCD. Because wording can vary, it’s helpful to ask the care team to explain what the test results mean for the individual’s treatment. The test itself is not a diagnosis or a direct treatment but a tool to help inform decisions.
What Functional Tumor Profiling Does Not Automatically Mean
It’s important to understand that EVA-PCD is not a guarantee that a certain drug will work or that it is the only option. The test results are one piece of information among many that doctors use. Also, because the test is done outside the body, it cannot perfectly predict how the tumor will respond inside the patient. Patients should avoid interpreting EVA-PCD results as a definitive treatment plan without discussing them with their care team.
How to Use Functional Tumor Profiling Information in Your Care
If EVA-PCD testing is part of your care, ask your doctors how the results fit with other tests and your overall treatment plan. Questions you might ask include what the test results suggest about different treatment options, how reliable the test is for your cancer type, and whether the test results will change your treatment. Understanding the context helps you make informed decisions alongside your care team.
Safety and Next Steps
This information about Functional Tumor Profiling / EVA-PCD is educational and does not replace medical advice. The test is one tool among many, and what is safe or appropriate depends on your unique situation. If you see EVA-PCD mentioned in your records or discussions, the best next step is to ask your care team to explain what it means for you in your specific case.